financetom
Business
financetom
/
Business
/
US misses out on billions in China soybean sales midway through peak season
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US misses out on billions in China soybean sales midway through peak season
Sep 9, 2025 10:06 PM

BEIJING/SINGAPORE/CHICAGO (Reuters) -U.S. farmers are missing out on billions of dollars of soybean sales to China halfway through their prime marketing season, as stalled trade talks halt exports and rival South American suppliers step in to fill the gap, traders and analysts said.

Chinese importers have booked around 7.4 million metric tons of mainly South American soybeans for October shipment, covering 95% of China's projected demand for the month and 1 million tons for November, or about 15% of expected imports, according to two Asia-based traders.

By this time last year, Chinese buyers had booked around 12 million to 13 million tons of U.S. soybeans for September-November shipment, said one of the traders, who is based in Singapore at an international trading company.

The U.S. normally ships most of its soybeans to China between September and January, before Brazil's harvest hits the market, but Chinese buyers have yet to book any U.S. cargoes for the new crop year, according to traders tracking shipments.

The U.S. sold some 22.9 million tons of soybeans to top buyer China in the marketing year that ran through August 2025. China purchased $12.8 billion of U.S. soybeans in 2024.

"If you look at the way things are, we think it is going to be South American beans through the end of the year," the Singapore trader said.

The prolonged absence of Chinese buying is expected to weigh further on benchmark Chicago soybean futures, already hovering near five-year lows.

U.S. soybeans are about 80 to 90 cents a bushel cheaper than Brazilian soybeans for September-October shipment, but China's 23% tariff on U.S. shipments adds $2 a bushel to the cost for importers, traders said.

The traders asked not to be named because they are not authorised to speak to media.

While other countries have been booking U.S. soybeans, Dan Basse, president of AgResource Co in Chicago, estimates that if China keeps out of the U.S. market until mid-November, total lost sales to the country could be as high as 14 million to 16 million tons.

The U.S. Department of Agriculture is likely to start trimming its 2025/26 U.S. soybean export forecast in its monthly World Agriculture Supply and Demand Estimates report on Friday, with further revisions likely if the trade war goes unresolved, he said.

In its previous outlook, the USDA pegged U.S. soybean exports at 46.4 million tons for 2025/26, already down from 51.02 million tons a year ago.

AWAITING TRADE PACT

Still, China has not completely closed its doors to U.S. soybeans, with plenty of purchasing still to be done for delivery in November through January.

"U.S. soybeans are currently attractively priced for many non-Chinese buyers, especially with limited competition during the peak selling season," said Johnny Xiang, founder of Beijing-based AgRadar Consulting.

"In contrast, strong Chinese demand has driven Brazilian soybean prices higher as their selling season winds down. If a China-U.S. trade deal is reached, the outlook for U.S. soybeans could improve significantly."

Expensive Brazilian soybeans threaten profits for Chinese oilseed processors, with crush margins in Rizhao, China's key processing hub, turning negative in the past two weeks after being positive in early August.

China's soybean imports hit record highs during May, June, July and August, boosting inventories, partly as a hedge by buyers against potential fourth-quarter supply disruptions.

"There's not much to say on China right now," said one U.S. soybean exporter. "If these were normal times, we'd be doing 15 cargoes a week."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved